SMi's 5th Annual Biosimilars USA Conference

Conference themes
This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S.
Fresh from the press: On March 7th, 2018, the U.S.-FDA's Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA.

Professional congress organizer (PCO)
SMi Group

Notes
URL:
Brochure: https://go.evvnt.com/236852-3?pid=4832

Speakers: Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Christina Yunis, Global Biosimilars Market Development Lead, Pfizer Essential Health, Nigel Rulewski and more

Tickets: https://go.evvnt.com/236852-0?pid=4832 Tickets: https://go.evvnt.com/236852-4?pid=4832

Ms. Simi Sapal